2

Competitive Costs of Disclosure by Biotech IPOs

Année:
2004
Langue:
english
Fichier:
PDF, 202 KB
english, 2004
4

On Corporate Divestiture

Année:
2005
Langue:
english
Fichier:
PDF, 217 KB
english, 2005
7

Information Collection and IPO Underpricing

Année:
2005
Langue:
english
Fichier:
PDF, 161 KB
english, 2005
8

Explaining the Short- and Long-Term IPO Anomalies in the US by R&D

Année:
2006
Langue:
english
Fichier:
PDF, 206 KB
english, 2006
9

Analysts' Selective Coverage and Subsequent Performance of Newly Public Firms

Année:
2006
Langue:
english
Fichier:
PDF, 184 KB
english, 2006
10

The option to withdraw IPOs during the premarket: empirical analysis

Année:
2001
Langue:
english
Fichier:
PDF, 193 KB
english, 2001
12

Undoing the powerful anti-takeover force of staggered boards

Année:
2008
Langue:
english
Fichier:
PDF, 286 KB
english, 2008
13

Ownership Structure and IPO Valuation—Evidence from Taiwan

Année:
2008
Langue:
english
Fichier:
PDF, 553 KB
english, 2008
15

Analysts' Selective Coverage and Subsequent Performance of Newly Public Firms

Année:
2006
Langue:
english
Fichier:
PDF, 3.62 MB
english, 2006
19

Metabolic effects of pamidronate in patients with metastatic bone disease

Année:
1996
Langue:
english
Fichier:
PDF, 1.42 MB
english, 1996
25

Ownership Structure and IPO Valuation: Evidence from Taiwan

Année:
2008
Langue:
english
Fichier:
PDF, 2.85 MB
english, 2008
29

Innovation capability and post-IPO performance

Année:
2016
Langue:
english
Fichier:
PDF, 356 KB
english, 2016
33

Bionic surface design of cemented carbide drill bit

Année:
2016
Langue:
english
Fichier:
PDF, 1.14 MB
english, 2016
39

The Valuation of Biotech IPOs

Année:
2004
Langue:
english
Fichier:
PDF, 134 KB
english, 2004
40

Undoing the Powerful Anti-Takeover Force of Staggered Boards

Année:
2006
Langue:
english
Fichier:
PDF, 202 KB
english, 2006
41

CAPM for Estimating the Cost of Equity Capital: Interpreting the Empirical Evidence

Année:
2010
Langue:
english
Fichier:
PDF, 363 KB
english, 2010